Autoimmune and proinflammatory activity of oxidized immunoglobulins.

Abstract:

AIMS:Oxidation reactions can modify protein activity or specificity. Recently, a novel redox-reactive family of autoantibodies was described, which indicated involvement of altered antibodies (beside altered antigens) into autoimmune reactions. The aim of our study was to determine the binding capacity alterations of electro-oxidized blood donors' IgGs, and to evaluate their effects on released proinflammatory interleukin 6 in HUVEC. RESULTS:We found out that 1.) Isolated blood donor IgGs bound after electro-oxidation to beta2-glycoprotein I, cardiolipin, citrullinated cyclic peptide and protein 3 by enzyme-linked immunosorbent assay, extractable nuclear antigens by counterimmuno-electrophoresis, and cell antigens by indirect immunofluorescence; 2.) Alterations in immunoreactivity of IgGs due to oxidation highly depend on electric current, time of exposure and the presence of antioxidants, 3.) Treatment of HUVEC with oxidized IgGs resulted in changed cell morphology, accompanied by an increase in released interleukin-6. CONCLUSIONS:Our data suggest repeatable transformation of antibodies present in the blood of healthy persons and patients. Inter-individual differences in chemical stability of antibodies, patient's antioxidant status, and the microenvironmental changes at the cellular level may influence the range of antibody alterations and their involvement in pathophysiological autoimmune processes.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Omersel J,Jurgec I,Cucnik S,Kveder T,Rozman B,Sodin-Semrl S,Bozic B

doi

10.1016/j.autrev.2008.04.005

subject

Has Abstract

pub_date

2008-07-01 00:00:00

pages

523-9

issue

7

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(08)00049-9

journal_volume

7

pub_type

杂志文章
  • Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis.

    abstract::Granulomatosis with polyangiitis (GPA) is an autoimmune systemic necrotizing small-vessel vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA). Oto-neurological manifestations of ANCA-associated vasculitis according to PR3-ANCA positivity and MPO-ANCA positivity are usually reported...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.005

    authors: Iannella G,Greco A,Granata G,Manno A,Pasquariello B,Angeletti D,Didona D,Magliulo G

    更新日期:2016-07-01 00:00:00

  • Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.

    abstract:BACKGROUND:Cardiac neonatal lupus syndrome is due to anti-SSA or SSB antibodies and mainly includes congenital heart block (CHB) and dilated cardiomyopathy (DCM). Its optimal management is still debated. We report a large series of autoimmune high degree CHB. METHODS:Inclusion criteria in this retrospective study were...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.08.005

    authors: Levesque K,Morel N,Maltret A,Baron G,Masseau A,Orquevaux P,Piette JC,Barriere F,Le Bidois J,Fermont L,Fain O,Theulin A,Sassolas F,Pezard P,Amoura Z,Guettrot-Imbert G,Le Mercier D,Georgin-Lavialle S,Deligny C,Hachull

    更新日期:2015-12-01 00:00:00

  • Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.

    abstract:BACKGROUND:Long-term anticoagulation is recommended in antiphospholipid syndrome with thrombosis in order to prevent recurrences. While the current mainstay relies on vitamin K antagonists, their long-term maintenance may remain challenging. OBJECTIVES:To report on the safety and the efficacy of oral direct inhibitors...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.03.007

    authors: Noel N,Dutasta F,Costedoat-Chalumeau N,Bienvenu B,Mariette X,Geffray L,Sene D,Chaidi RB,Michot JM,Fain O,Darnige L,Ankri A,Cacoub P,Piette JC,Saadoun D

    更新日期:2015-08-01 00:00:00

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    abstract::The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives of this Task Force were to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, prec...

    journal_title:Autoimmunity reviews

    pub_type:

    doi:10.1016/j.autrev.2014.03.002

    authors: Cervera R,Rodríguez-Pintó I,Colafrancesco S,Conti F,Valesini G,Rosário C,Agmon-Levin N,Shoenfeld Y,Ferrão C,Faria R,Vasconcelos C,Signorelli F,Espinosa G

    更新日期:2014-07-01 00:00:00

  • Set a thief to catch a thief: self-reactive innate lymphocytes and self tolerance.

    abstract::Self-reactive lymphocytes form part of the peripheral repertoire in healthy individuals. Some of these cells are anergic classical lymphocytes, but a remarkable subset of self-reactive clones is related to innate immunity and many of them bear a partially activated phenotype. In the past few years growing evidence has...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.10.002

    authors: Kristóf K,Erdei A,Bajtay Z

    更新日期:2008-02-01 00:00:00

  • Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

    abstract:OBJECTIVE:Although in most patients induction therapy leads to complete or partial remission, relapses in patients with non-infectious mixed cryoglobulinemia vasculitis (CryoVas) remain a major problem. We aimed to identify predictors of early relapses occurring within the first 12months of treatment in such patients. ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.11.006

    authors: Terrier B,Marie I,Launay D,Lacraz A,Belenotti P,de Saint-Martin L,Quemeneur T,Huart A,Bonnet F,Le Guenno G,Kahn JE,Hinschberger O,Rullier P,Diot E,Lazaro E,Bridoux F,Zénone T,Carrat F,Hermine O,Léger JM,Mariette X

    更新日期:2014-06-01 00:00:00

  • Polymerase-1 pathway activation in acute multiple sclerosis relapse.

    abstract:BACKGROUND:Increased expression of RNA polymerase 1 (POL1) molecular pathway was reported to be associated with increased disease activity in patients with multiple sclerosis (MS). However, the operating molecular mechanisms that characterize the pattern of acute MS relapse activity has not been thoroughly studied. OB...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.07.006

    authors: Achiron A,Zilkha-Falb R,Feldman A,Bovim M,Rozen O,Sarova-Pinhas I,Magalashvili D,Dolev M,Menascu S,Gurevich M

    更新日期:2018-12-01 00:00:00

  • Interaction of pregnancy and autoimmune rheumatic disease.

    abstract::During pregnancy, the fetus represents a natural allograft that is not normally rejected. While the maternal immune system retains the ability to respond to foreign antigens, tolerance mechanisms are up-regulated to protect the fetus from immunologic attacks by the mother. The profound immunologic adaptations during a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.013

    authors: Østensen M,Villiger PM,Förger F

    更新日期:2012-05-01 00:00:00

  • Regulation of Fli1 gene expression and lupus.

    abstract::Ets transcription factors function throughout development in such varied processes as cellular proliferation, apoptosis, differentiation and migration. Many have been implicated to play important roles in hematopoiesis, vasculogenesis/angiogenesis and myogenesis. Fli1 is an Ets family member that is essential for deve...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.10.005

    authors: Nowling TK,Gilkeson GS

    更新日期:2006-07-01 00:00:00

  • Geoepidemiological hints about Streptococcus pyogenes strains in relationship with acute rheumatic fever.

    abstract::Group A Streptococcus (GAS) strains are lately classified on the basis of sequence variations in the emm gene encoding the M protein, but despite the high number of distinct emm genotypes, the spectrum of phenotypes varying from invasive suppurative to non-suppurative GAS-related disorders has still to be defined. The...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.03.001

    authors: Esposito S,Bianchini S,Fastiggi M,Fumagalli M,Andreozzi L,Rigante D

    更新日期:2015-07-01 00:00:00

  • Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.

    abstract:BACKGROUND:The gold standard for secondary thromboprophylaxis in APS is long term anticoagulation with vitamin K antagonists (VKAs). Because of their widespread use and potential advantages of directs oral anticoagulants (DOACs) over VKAs, they have been prescribed in APS without definitive evidence of their safety and...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2020.102711

    authors: Dufrost V,Wahl D,Zuily S

    更新日期:2021-01-01 00:00:00

  • Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases.

    abstract:OBJECTIVE:To describe the clinical and immunologic features of 6 patients with rheumatic disease and Hepatitis C Virus (HCV) chronic infection, treated with anti-TNF alpha drugs. PATIENTS AND METHODS:Six patients, with repeated positive serology for HCV infection, were affected by Rheumatoid arthritis (RA) (4 cases), ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.05.002

    authors: Cavazzana I,Ceribelli A,Cattaneo R,Franceschini F

    更新日期:2008-12-01 00:00:00

  • Use of rituximab in patients with systemic lupus erythematosus: an update.

    abstract::Systemic lupus erythematosus (SLE) is a chronic, occasionally life threatening, multisystem disorder. Patients suffer from a wide group of symptoms and have a variable prognosis that depends of the severity and type of organ involvement. The clinical manifestations include fever, skin lesions, arthritis, neurologic, r...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.11.006

    authors: García-Carrasco M,Jiménez-Hernández M,Escárcega RO,Mendoza-Pinto C,Galarza-Maldonado C,Sandoval-Cruz M,Zamudio-Huerta L,López-Colombo A,Cervera R

    更新日期:2009-02-01 00:00:00

  • Is primary biliary cirrhosis a model autoimmune disease?

    abstract::Primary biliary cirrhosis (PBC) has been coined a model autoimmune disease. In fact, it does share many similarities with other autoimmune diseases, but there are striking differences that illustrate the uniqueness of the immunopathology. Firstly, similar to other autoimmune diseases, there is an intense humoral and c...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.04.001

    authors: Ichiki Y,Shimoda S,Ishibashi H,Gershwin ME

    更新日期:2004-06-01 00:00:00

  • Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.

    abstract::Dendritic cells (DCs) constitute a heterogeneous population of professional antigen presenting cells which are the initiators and key regulators for both immunity and tolerance induction. The significance and impact of DC biology in contemporary immunology and medical research is heightened by the award of the 2011 No...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.03.004

    authors: Chan VS,Nie YJ,Shen N,Yan S,Mok MY,Lau CS

    更新日期:2012-10-01 00:00:00

  • Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.

    abstract:OBJECTIVE:To describe safety and efficacy of rituximab in patients with systemic sclerosis. METHODS:We included 13 patients with systemic sclerosis treated with rituximab and pooled with 40 additional patients from the literature. SSc rituximab untreated patients were matched to rituximab treated ones. RESULTS:Thirte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2017.12.010

    authors: Thiebaut M,Launay D,Rivière S,Mahévas T,Bellakhal S,Hachulla E,Fain O,Mekinian A

    更新日期:2018-06-01 00:00:00

  • X chromosome monosomy in primary and overlapping autoimmune diseases.

    abstract::Female predominance is a common characteristic for autoimmune diseases attributed to the combined effect of hormonal influence and genetic factors. Since X chromosome has immunologically important genes, the age related X chromosome loss could contribute to the development of autoimmunity. X chromosome monosomy (XCM) ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.001

    authors: Svyryd Y,Hernández-Molina G,Vargas F,Sánchez-Guerrero J,Segovia DA,Mutchinick OM

    更新日期:2012-03-01 00:00:00

  • B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?

    abstract::Natriuretic peptides (NP) are secreted by cardiomyocytes and are reliable markers of cardiac dysfunction and cardiovascular risk by reflecting myocardial stress due to various etiologies. Clinical and occult heart involvement is frequently observed in patients with rheumatic diseases and is associated with increased m...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.02.018

    authors: Dimitroulas T,Giannakoulas G,Karvounis H,Garyfallos A,Settas L,Kitas G

    更新日期:2012-10-01 00:00:00

  • Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin.

    abstract:BACKGROUND:Ferritin and prolactin have been associated with active autoimmune diseases as systemic lupus erythematosus and autoantibody production, but have been little studied in viral infections that present autoimmunity. OBJECTIVE:To investigate the association of these two autoimmune mediators with the presence of...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2010.10.003

    authors: Sousa GM,Oliveira RC,Pereira MM,Paraná R,Sousa-Atta ML,Atta AM

    更新日期:2011-02-01 00:00:00

  • Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

    abstract::A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at the time of the diagnosis of SSc. The study was based on the Spanish Scleroderma Registry (RESCLE). The cohort was split up in der...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102507

    authors: Rubio-Rivas M,Corbella X,Guillén-Del-Castillo A,Tolosa Vilella C,Colunga Argüelles D,Argibay A,Vargas Hitos JA,Todolí Parra JA,González-Echávarri C,Ortego-Centeno N,Trapiella Martínez L,Rodríguez Carballeira M,Marín Ballvé A,Pl

    更新日期:2020-05-01 00:00:00

  • Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review.

    abstract:BACKGROUND:Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a rare multi-system autoimmune disease, characterised by a pauci-immune necrotising small-vessel vasculitis, with a relapsing and remitting course. Like many autoimmune diseases, the exact aetiology of AAV, and the factors that influenc...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102660

    authors: Scott J,Hartnett J,Mockler D,Little MA

    更新日期:2020-11-01 00:00:00

  • CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.

    abstract::There is strong evidence that a quantitative and/or functional deficiency in CD4+CD25+ regulatory T cells (T(reg) cells) plays a key role in the pathogenesis of many human autoimmune diseases. Therefore, targeting regulatory T cells with novel forms of immunotherapy should provide a means for successfully battling aut...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2005.06.001

    authors: Beyersdorf N,Hanke T,Kerkau T,Hünig T

    更新日期:2006-01-01 00:00:00

  • Modulation of autoimmunity with artificial peptides.

    abstract::The loss of immune tolerance to self antigens leads to the development of autoimmune responses. Since self antigens are often multiple and/or their sequences may be known, one approach to restore immune tolerance uses synthetic artificial peptides that interfere or compete with self peptides in the networks of cellula...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.017

    authors: La Cava A

    更新日期:2010-11-01 00:00:00

  • Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.

    abstract:OBJECTIVE:To address changes in survival of patients with systemic lupus erythematosus (SLE) and to compare mortality statistics with associated disease specific as well as comorbid conditions. METHODS:Review of the international literature on survival of patients with SLE. RESULTS:During the first half of the 20th c...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.04.002

    authors: Borchers AT,Keen CL,Shoenfeld Y,Gershwin ME

    更新日期:2004-08-01 00:00:00

  • Insights into IL-37, the role in autoimmune diseases.

    abstract::Autoimmune diseases are characterized by the impaired function and the destruction of tissues that are caused by an immune response in which aberrant antibodies are generated and attack the body's own cells and tissues. Interleukin (IL) -37, a new member of the IL-1 family, broadly reduces innate inflammation as well ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.08.006

    authors: Xu WD,Zhao Y,Liu Y

    更新日期:2015-12-01 00:00:00

  • Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells.

    abstract::Analysis of autoantibodies (AAB) by indirect immunofluorescence (IIF) remains the hallmark of diagnosing autoimmune diseases despite the introduction of multiplex techniques. Non-organ specific AAB are screened in routine diagnostics by IIF on HEp-2 cells. However, IIF results vary due to objective (e.g., cell fixatio...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.02.033

    authors: Hiemann R,Büttner T,Krieger T,Roggenbuck D,Sack U,Conrad K

    更新日期:2009-09-01 00:00:00

  • Diagnosis and classification of pernicious anemia.

    abstract::Pernicious anemia (PA) is a complex disorder consisting of hematological, gastric and immunological alterations. Diagnosis of PA relies on histologically proven atrophic body gastritis, peripheral blood examination showing megaloblastic anemia with hypersegmented neutrophils, cobalamin deficiency and antibodies to int...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.042

    authors: Bizzaro N,Antico A

    更新日期:2014-04-01 00:00:00

  • Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.

    abstract::T cells from patients with SLE produce decreased amounts of interleukin-2 (IL-2), a central cytokine in the regulation of the immune response. We discuss herein the abnormalities underlying IL-2 deficiency in SLE T cells. ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.08.009

    authors: Katsiari CG,Tsokos GC

    更新日期:2006-02-01 00:00:00

  • CD20: a target antigen for immunotherapy of autoimmune diseases.

    abstract::This article reviews the role of CD20 antigen in B cell function and the effectiveness and limits of passive immunotherapy with anti-CD20 monoclonal antibody (Rituximab) in the treatment of autoimmune (or immune-mediated) diseases. Active immunotherapy is a more feasible way to control these chronic diseases. A peptid...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.04.004

    authors: Perosa F,Favoino E,Caragnano MA,Prete M,Dammacco F

    更新日期:2005-11-01 00:00:00

  • Leflunomide in psoriatic arthritis.

    abstract::Psoriatic arthritis (PsA) is a common unique form of inflammatory arthritis associated with psoriasis. Its exact prevalence is unknown but 5-30% of the 2-3% of subjects of the general population affected with psoriasis are developing PsA. Typically PsA presents as an oligoarticular asymmetrical arthritis with predomin...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.12.001

    authors: Kaltwasser JP

    更新日期:2007-09-01 00:00:00